LRRK2 and Parkinson disease: We hypothesized that the NTDs of LRRK2 (ARM, ANK, and LRR) play an inhibitory regulatory role acting as a “lid,” which is “unleashed” physiologically by activated Rab proteins but also by some of the PD mutations.